Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur M Feldman

Showing results (171-180 of 224) with videos related to

Pageof 23
Sort By:
European Journal of Heart Failure|May 1, 2022
The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual patient data meta-analysis of COMPANION and CARE-HFJohn G F Cleland, Michael R Bristow, Nicholas Freemantle, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 6, 2011
Myocardial injury after ischemia-reperfusion in mice deficient in Akt2 is associated with increased cardiac macrophage densityXue Li, Deana Mikhalkova, Erhe Gao, et al.
Journal of Molecular and Cellular Cardiology|April 15, 2004
Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditisZhonghua Tang, Brian S McGowan, Sally A Huber, et al.
Journal of Cellular Physiology|January 15, 2019
Trpm2 enhances physiological bioenergetics and protects against pathological oxidative cardiac injury: Role of Pyk2 phosphorylationBarbara A Miller, JuFang Wang, Jianliang Song, et al.
Clinical and Translational Science|August 25, 2015
Cardiac Dysfunction in HIV-1 Transgenic Mouse: Role of Stress and BAG3Joseph Y Cheung, Jennifer Gordon, JuFang Wang, et al.
Clinical Science (London, England : 1979)|September 4, 2016
Vasopressin type 1A receptor deletion enhances cardiac contractility, β-adrenergic receptor sensitivity and acute cardiac injury-induced dysfunctionMelissa A Wasilewski, Laurel A Grisanti, Jianliang Song, et al.
The New England Journal of Medicine|May 21, 2004
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failureMichael R Bristow, Leslie A Saxon, John Boehmer, et al.
Journal of Cellular Physiology|May 12, 2017
Dysregulation of mitochondrial bioenergetics and quality control by HIV-1 Tat in cardiomyocytesFarzaneh G Tahrir, Santhanam Shanmughapriya, Taha Mohseni Ahooyi, et al.
Journal of the American College of Cardiology|July 21, 2004
Working group 1: How to increase the output of cardiologistsKenneth Lee Baughman, Carl J Pepine, Jonathan Abrams, et al.
Circulation|April 18, 2007
A1 adenosine receptor upregulation accompanies decreasing myocardial adenosine levels in mice with left ventricular dysfunctionHajime Funakoshi, Lefteris C Zacharia, Zhonghua Tang, et al.
Pageof 23

Showing results (171-180 of 224) with videos related to

Sort By:
Pageof 23
European Journal of Heart Failure|May 1, 2022
The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual patient data meta-analysis of COMPANION and CARE-HFJohn G F Cleland, Michael R Bristow, Nicholas Freemantle, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 6, 2011
Myocardial injury after ischemia-reperfusion in mice deficient in Akt2 is associated with increased cardiac macrophage densityXue Li, Deana Mikhalkova, Erhe Gao, et al.
Journal of Molecular and Cellular Cardiology|April 15, 2004
Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditisZhonghua Tang, Brian S McGowan, Sally A Huber, et al.
Journal of Cellular Physiology|January 15, 2019
Trpm2 enhances physiological bioenergetics and protects against pathological oxidative cardiac injury: Role of Pyk2 phosphorylationBarbara A Miller, JuFang Wang, Jianliang Song, et al.
Clinical and Translational Science|August 25, 2015
Cardiac Dysfunction in HIV-1 Transgenic Mouse: Role of Stress and BAG3Joseph Y Cheung, Jennifer Gordon, JuFang Wang, et al.
Clinical Science (London, England : 1979)|September 4, 2016
Vasopressin type 1A receptor deletion enhances cardiac contractility, β-adrenergic receptor sensitivity and acute cardiac injury-induced dysfunctionMelissa A Wasilewski, Laurel A Grisanti, Jianliang Song, et al.
The New England Journal of Medicine|May 21, 2004
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failureMichael R Bristow, Leslie A Saxon, John Boehmer, et al.
Journal of Cellular Physiology|May 12, 2017
Dysregulation of mitochondrial bioenergetics and quality control by HIV-1 Tat in cardiomyocytesFarzaneh G Tahrir, Santhanam Shanmughapriya, Taha Mohseni Ahooyi, et al.
Journal of the American College of Cardiology|July 21, 2004
Working group 1: How to increase the output of cardiologistsKenneth Lee Baughman, Carl J Pepine, Jonathan Abrams, et al.
Circulation|April 18, 2007
A1 adenosine receptor upregulation accompanies decreasing myocardial adenosine levels in mice with left ventricular dysfunctionHajime Funakoshi, Lefteris C Zacharia, Zhonghua Tang, et al.
Pageof 23